The Valley Desk

ArticleBritish journal of haematologyPublished

A real-world multi-institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B-cell acute lymphoblastic leukaemia

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
British journal of haematology
Published
Subject terms
Leukaemia; Paediatrics; Inotuzumab Ozogamicin; Real‐world Study; Relapsed/refractory B‐cell Acute Lymphoblastic Leukaemia
PubMed ID
42899382
Added to directory
Source checked

Report a correction or request removal